Applegate R A, Soriano T, Perry C, Elam J
J Am Optom Assoc. 1986 Aug;57(8):604-6.
A case report revealing two previously unreported adverse side effects of meprobamate and tridihexethyl chloride (Milpath) drug therapy for a spastic colon is presented. The two previously unreported adverse effects are a diffuse loss of color discrimination and an increased time course to complete dark adaptation.
本文报告了一例关于使用眠尔通和氯化三乙环苯啶（米尔帕斯）治疗痉挛性结肠时出现两种此前未报告的不良反应的病例。这两种此前未报告的不良反应是色觉辨别能力的弥漫性丧失以及完成暗适应所需时间增加。
